000 00920 a2200217 4500
005 20250517120350.0
008 ####s 0 0 eng d
022 _a1432-0851
024 7 _a10.1007/s00262-016-1903-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRichards, John O
245 0 0 _aErratum to: NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells.
_h[electronic resource]
260 _bCancer immunology, immunotherapy : CII
_c11 2016
300 _a1337 p.
_bdigital
500 _aPublication Type: Journal Article; Published Erratum
700 1 _aAlbers, Alex J
700 1 _aSmith, Thomas S
700 1 _aTjoe, Judy A
773 0 _tCancer immunology, immunotherapy : CII
_gvol. 65
_gno. 11
_gp. 1337
856 4 0 _uhttps://doi.org/10.1007/s00262-016-1903-9
_zAvailable from publisher's website
999 _c26477563
_d26477563